Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2026-07-30 16:34:01 ET · period of report 2026-07-28 · accession 0001437749-26-025082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 16:34 | 2026-07-28 | AYTU | PYSZCZYMUKA GREG | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 56.1K | +55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | A | A | 20,000 | $0.00 | 56,102 | D | — | — | (F1) Grant of restricted stock, which vest as follows: 1/3 on July 28, 2027, with the remaining restricted stock vesting in 8 equal quarterly installments beginning October 28, 2027. |